Non-irritating, non-blurring, photostable ophthalmic sunscreen composition
AssigneeA. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation
InventorA. Ebbie Soroudi
Life of this patent
Estimating the term…
Loading patent…
AssigneeA. Ebbie Soroudi, M.D., M.S., A Professional Medical Corporation
InventorA. Ebbie Soroudi
Estimating the term…
A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.
A method for protecting an eye from ultraviolet (UV) radiation damage, the method comprising administering an ophthalmic sunscreen composition to an ocular surface of said eye, wherein said ophthalmic sunscreen composition comprises:
Dependencies are inferred from the claim text.